Correlation Between Adial Pharmaceuticals and Iterum Therapeutics

Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Iterum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Iterum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adial Pharmaceuticals and Iterum Therapeutics PLC, you can compare the effects of market volatilities on Adial Pharmaceuticals and Iterum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Iterum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Iterum Therapeutics.

Diversification Opportunities for Adial Pharmaceuticals and Iterum Therapeutics

0.84

Correlation Coefficient

Adial Pharmaceuticals  Iterum Therapeutics

Very poor diversification

The 3 months correlation between Adial and Iterum is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Iterum Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iterum Therapeutics PLC and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Iterum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iterum Therapeutics PLC has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Iterum Therapeutics go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and Iterum Therapeutics

Given the investment horizon of 90 days Adial Pharmaceuticals is expected to under-perform the Iterum Therapeutics. In addition to that, Adial Pharmaceuticals is 1.55 times more volatile than Iterum Therapeutics PLC. It trades about -0.12 of its total potential returns per unit of risk. Iterum Therapeutics PLC is currently generating about -0.16 per unit of volatility. If you would invest  190.00  in Iterum Therapeutics PLC on December 27, 2024 and sell it today you would lose (57.00) from holding Iterum Therapeutics PLC or give up 30.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.36%
Values	Daily Returns

Adial Pharmaceuticals  vs.  Iterum Therapeutics PLC

Adial Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Iterum Therapeutics PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Iterum Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Adial Pharmaceuticals and Iterum Therapeutics

The main advantage of trading using opposite Adial Pharmaceuticals and Iterum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Iterum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iterum Therapeutics will offset losses from the drop in Iterum Therapeutics' long position.

The idea behind Adial Pharmaceuticals and Iterum Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.